Position in SRPT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$15,227,539
-$434,415 QoQ
Shares Held
699,795
-3.8% QoQ
Ownership
0.663%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$6,840
PutShares
400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. SRPT ranks #47 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,227,539 | 699,795 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,661,954 | 727,786 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $34,326,575 | 1,781,348 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,840 | 400 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $21,097,107 | 1,233,749 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,170,390 | 34,008 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,337,402 | 27,448 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $1,215 | 10 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $3,413,368 | 27,331 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $11,822,508 | 74,826 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $29,177,953 | 225,382 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $14,312,719 | 148,426 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,664,480 | 30,230 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,339,071 | 20,425 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $21,915,107 | 159,001 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,869,227 | 37,577 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $5,226,511 | 69,724 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,230,048 | 130,953 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $12,931,990 | 143,609 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $5,639,800 | 60,984 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $2,857,022 | 36,751 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,238,253 | 43,449 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $4,519,689 | 26,510 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $3,370,460 | 24,001 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $5,348,140 | 33,355 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $3,783,188 | 38,675 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||